Americans generally agree science has improved the quality of healthcare, but the vast majority consider it unaffordable, according to a recent Pew Research Center survey.
The FDA has cleared a less-invasive implant approach for Medtronic’s HeartWare HVAD system, allowing the left ventricular assist device (LVAD) to be placed through a small incision between the ribs. It is the first LVAD approved in the U.S. to be inserted with this technique, according to Medtronic.
Valsartan, a common drug used to control hypertension and heart failure, is being recalled in 22 counties due to concerns its active pharmaceutical ingredient, N-Nitrosodimethylamine (NDMA), a known carcinogen, poses a cancer risk.
James A. Haley Veterans’ Hospital in Florida is one of the eight U.S. Department of Veterans Affairs (VA) institutions investigators have contacted as part of an audit to see if the VA processed radiology requests within a proper time frame and adequately managed canceled requests, the Tampa Bay Times reported.
Quantitative flow ratio (QFR) allows for the functional assessment of stenosis on par with fractional flow reserve (FFR) but doesn’t require a guidewire, an international group of researchers reported in the Journal of the American Heart Association.
A custom-built computer, dubbed SpiNNaker, which mimics the brain’s neural networks, is helping researchers learn more about conditions including epilepsy and Alzheimer’s disease.
Todd Minnigh, Carestream Health’s vice president of global service sales, will deliver a presentation about innovation, creation and motivating employees at AHRA 2018 in Orlando.
Updated radiotracers marketed for use in cancer diagnosis and targeted therapies could carry substantial health risks for premenopausal women that aren’t echoed in men, three New York physicians reported in a Radiology editorial this month.
A team of U.S. researchers has uncovered the exact point when normal, healthy protein becomes toxic but has yet to form tangles. Experts believe the findings could be a target for developing Alzheimer's treatments.
